Volatile Anaesthesia and Cancer Recurrence

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The choice of anaesthetic agent used during cancer surgery could reduce the chances that the tumour will relapse, according to our preliminary findings. Surgery releases stress hormones and inflammatory molecules, which we have shown to increase the chance of cancer recurrence. The proposed study explores how the choice of anaesthetic agent used in cancer surgery can block the adverse effects of surgical stress, and stop cancer coming back.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $656,579.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anaesthetics | cancer care | inflammation | stress response | surgery